Allergan (AGN): Staying Long The Headache

08/14/08 04:52PM EDT
My Partner, Tom Tobin, has been in and out of this stock for a long time. Since his portal is still on free trial you can see the AGN call he made last weekend titled "Trading Long Into The Headache Data".

My models have this "Trade" going to $59.34 in the immediate term, at least.
KM
  • AGN short term target $59.34
(chart courtesy of StockCharts.com)
© 2020 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.